Andrew Leber, Ph.D. contributes deep knowledge of immunology, advanced computational modeling, data analytics, AI, and drug development to Landos Biopharma. As the Executive Scientific Director, he is responsible for assessing the therapeutic potential of lead immunoregulatory targets in autoimmune diseases.